Literature DB >> 7705584

[Prevalence of hepatitis C, B and D markers and histopathological aspects in a group of intravenous drug addicts].

D Lucidarme1, P Foutrein, C Creusy, G Forzy, M C Foutrein-Comes, A Muyssen, D Bailly, P J Parquet, B Filoche.   

Abstract

OBJECTIVES: The aim of this study was to assess the prevalence of infection by HCV, HBV, HDV and HIV and their biological and histopathological patterns in 104 intravenous drug users. METHODS AND
RESULTS: Seventy-five patients (72%) had anti-HCV antibodies. Transmission was rapid because 33% of those who had been drug users for 6 months or less had anti-HCV antibodies. The contamination rate was very high because 90% of those who had been drug users for 2 years or less had anti-HCV antibodies. Thirty-four (33%) had an HBV marker, and 6 were HBs Ag carriers. None of the patients had anti-HDV antibodies. Only one patient had anti-HIV antibodies. Twenty-five anti-HCV antibody positive drug users underwent liver biopsy. Seven (28%) had normal ALAT levels and 18 (72%) had permanently or intermittently elevated ALAT levels. The mean histological activity on the Knodell index was 4.1 (range: 1-8).
CONCLUSIONS: This study indicates that contamination by HCV is almost inevitable after 2 years of intravenous drug use. The low prevalence of HBV, HDV, and HIV infection might be explained by a low endemic state of these viruses in our area.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7705584

Source DB:  PubMed          Journal:  Gastroenterol Clin Biol        ISSN: 0399-8320


  3 in total

1.  Correlation of genotypes and route of transmission with histologic activity and disease stage in chronic hepatitis C.

Authors:  F Ramalho; A Costa; A Pires; P Cabrita; F Serejo; A P Correia; N Fatela; H Clória; J Lopes; H C Pinto; R Marinho; M Raimundo; J Velosa; A Batista; M C de Moura
Journal:  Dig Dis Sci       Date:  2000-01       Impact factor: 3.199

2.  Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.

Authors:  O E Santana Rodríguez; M L Malé Gil; J F HernándezSantana; J M Limiñana Cañal; A M Martín Sánchez
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

3.  Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial.

Authors:  Perrine Roux; Laurent Michel; Julien Cohen; Marion Mora; Alain Morel; Jean-Francois Aubertin; Jean-Claude Desenclos; Bruno Spire; Patrizia M Carrieri
Journal:  BMC Public Health       Date:  2012-06-28       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.